401
|
Lee CC, Lorenzo C, Haffner SM, Wagenknecht LE, Festa A, Goodarzi MO, Stefanovski D, Olson NC, Norris JM, Rewers MJ, Hanley AJ. The association of inflammatory and fibrinolytic proteins with 5 year change in insulin clearance: the Insulin Resistance Atherosclerosis Study (IRAS). Diabetologia 2013; 56:112-20. [PMID: 23052060 PMCID: PMC4010386 DOI: 10.1007/s00125-012-2741-8] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2012] [Accepted: 09/11/2012] [Indexed: 01/23/2023]
Abstract
AIMS/HYPOTHESIS Insulin clearance may decline as an early mechanism compensating for deteriorating insulin sensitivity. However, no previous studies have investigated the association between subclinical inflammation or impaired fibrinolysis and insulin clearance. We examined the association between plasminogen activator inhibitor (PAI)-1, C-reactive protein (CRP), TNF-α, leptin and fibrinogen and the progression of metabolic clearance rate of insulin (MCRI) over time. METHODS We studied 784 non-diabetic white, Hispanic and African-American individuals in the Insulin Resistance Atherosclerosis Study (IRAS). Insulin sensitivity, acute insulin response and MCRI were determined from frequently sampled intravenous glucose tolerance tests at baseline and at 5-year follow-up. Inflammatory and fibrinolytic proteins were measured in fasting plasma at baseline. RESULTS MCRI had declined significantly by 29% at the 5-year follow-up. We observed a significant association between higher plasma PAI-1 levels and the decline in MCRI in multivariable-adjusted regression models (β = -0.045 [95% CI -0.081, -0.0091]). Higher plasma CRP and leptin levels were associated with a decline in MCRI in unadjusted models, but these associations were non-significant after adjusting for BMI and waist circumference (β = -0.016 [95% CI -0.041, 0.0083] for CRP; β = -0.044 [95% CI -0.10, 0.011] for leptin). A higher plasma TNF-α concentration was associated with a decline in MCRI in unadjusted (β = -0.071 [95% CI -0.14, -0.00087]) but not in multivariable-adjusted (β = -0.056 [95% CI -0.13, 0.017]) models. Plasma fibrinogen level was not associated with the change in MCRI. CONCLUSIONS/INTERPRETATION We identified that higher plasma PAI-1 (but not CRP, TNF-α, leptin or fibrinogen) levels independently predicted the progressive decline of insulin clearance in the multiethnic cohort of the IRAS.
Collapse
Affiliation(s)
- C. C. Lee
- Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada
| | - C. Lorenzo
- Division of Clinical Epidemiology, University of Texas Health Science Centre, San Antonio, TX, USA
| | - S. M. Haffner
- Department of Medicine, Baylor College of Medicine, Houston, TX, USA
| | - L. E. Wagenknecht
- Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA
| | | | - M. O. Goodarzi
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - D. Stefanovski
- Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, CA, USA
| | - N. C. Olson
- Department of Pathology, University of Vermont College of Medicine, Burlington, VT
| | - J. M. Norris
- Department of Epidemiology, Colorado School of Public Health, University of Colorado, Aurora, CO, USA
| | - M. J. Rewers
- Barbara Davis Center for Diabetes, University of Colorado School of Medicine, Aurora, CO, USA
| | - A. J. Hanley
- Department of Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada
- Department of Medicine and Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada
- Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada
| |
Collapse
|
402
|
Baker NA, Karounos M, English V, Fang J, Wei Y, Stromberg A, Sunkara M, Morris AJ, Swanson HI, Cassis LA. Coplanar polychlorinated biphenyls impair glucose homeostasis in lean C57BL/6 mice and mitigate beneficial effects of weight loss on glucose homeostasis in obese mice. ENVIRONMENTAL HEALTH PERSPECTIVES 2013; 121:105-10. [PMID: 23099484 PMCID: PMC3553436 DOI: 10.1289/ehp.1205421] [Citation(s) in RCA: 96] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/03/2012] [Accepted: 10/24/2012] [Indexed: 05/16/2023]
Abstract
BACKGROUND Previous studies demonstrated that coplanar polychlorinated biphenyls (PCBs) promote proinflammatory gene expression in adipocytes. PCBs are highly lipophilic and accumulate in adipose tissue, a site of insulin resistance in persons with type 2 diabetes. OBJECTIVES We investigated the in vitro and in vivo effects of coplanar PCBs on adipose expression of tumor necrosis factor α (TNF-α) and on glucose and insulin homeostasis in lean and obese mice. METHODS We quantified glucose and insulin tolerance, as well as TNF-α levels, in liver, muscle, and adipose tissue of male C57BL/6 mice administered vehicle, PCB-77, or PCB-126 and fed a low fat (LF) diet. Another group of mice administered vehicle or PCB-77 were fed a high fat (HF) diet for 12 weeks; the diet was then switched from HF to LF for 4 weeks to induce weight loss. We quantified glucose and insulin tolerance and adipose TNF-α expression in these mice. In addition, we used in vitro and in vivo studies to quantify aryl hydrocarbon receptor (AhR)-dependent effects of PCB-77 on parameters of glucose homeostasis. RESULTS Treatment with coplanar PCBs resulted in sustained impairment of glucose and insulin tolerance in mice fed the LF diet. In PCB-77-treated mice, TNF-α expression was increased in adipose tissue but not in liver or muscle. PCB-77 levels were strikingly higher in adipose tissue than in liver or serum. Antagonism of AhR abolished both in vitro and in vivo effects of PCB-77. In obese mice, PCB-77 had no effect on glucose homeostasis, but glucose homeostasis was impaired after weight loss. CONCLUSIONS Coplanar PCBs impaired glucose homeostasis in lean mice and in obese mice following weight loss. Adipose-specific elevations in TNF-α expression by PCBs may contribute to impaired glucose homeostasis.
Collapse
Affiliation(s)
- Nicki A Baker
- Graduate Center for Nutritional Sciences, University of Kentucky, Lexington, Kentucky 40536-0200, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
403
|
Sakurai T, Ogasawara J, Kizaki T, Sato S, Ishibashi Y, Takahashi M, Kobayashi O, Oh-ishi S, Nagasawa J, Takahashi K, Ishida H, Izawa T, Ohno H. The effects of exercise training on obesity-induced dysregulated expression of adipokines in white adipose tissue. Int J Endocrinol 2013; 2013:801743. [PMID: 24369466 PMCID: PMC3867917 DOI: 10.1155/2013/801743] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/06/2013] [Revised: 10/07/2013] [Accepted: 10/10/2013] [Indexed: 01/03/2023] Open
Abstract
Obesity is recognized as a risk factor for lifestyle-related diseases such as type 2 diabetes and cardiovascular disease. White adipose tissue (WAT) is not only a static storage site for energy; it is also a dynamic tissue that is actively involved in metabolic reactions and produces humoral factors, such as leptin and adiponectin, which are collectively referred to as adipokines. Additionally, because there is much evidence that obesity-induced inflammatory changes in WAT, which is caused by dysregulated expression of inflammation-related adipokines involving tumor necrosis factor- α and monocyte chemoattractant protein 1, contribute to the development of insulin resistance, WAT has attracted special attention as an organ that causes diabetes and other lifestyle-related diseases. Exercise training (TR) not only leads to a decrease in WAT mass but also attenuates obesity-induced dysregulated expression of the inflammation-related adipokines in WAT. Therefore, TR is widely used as a tool for preventing and improving lifestyle-related diseases. This review outlines the impact of TR on the expression and secretory response of adipokines in WAT.
Collapse
Affiliation(s)
- Takuya Sakurai
- Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
- *Takuya Sakurai:
| | - Junetsu Ogasawara
- Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
| | - Takako Kizaki
- Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
| | - Shogo Sato
- Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
| | - Yoshinaga Ishibashi
- Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
| | - Motoko Takahashi
- Department of Biochemistry, Sapporo Medical University School of Medicine, South-1 West-17, Chuo-ku, Sapporo, Hokkaido 060-8556, Japan
| | - Osamu Kobayashi
- Department of Nursing, Kyorin University, Faculty of Health Science, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
| | - Shuji Oh-ishi
- Department of Respiratory Medicine, Hachioji Medical Center, Tokyo Medical University, 1163 Tatemachi, Hachioji, Tokyo 193-0998, Japan
| | - Junichi Nagasawa
- Department of Applied Physics and Chemistry, The University of Electro-Communications, 1-5-1 Chofugaoka, Chofu, Tokyo 182-8585, Japan
| | - Kazuto Takahashi
- Third Department of Internal Medicine, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
| | - Hitoshi Ishida
- Third Department of Internal Medicine, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
| | - Tetsuya Izawa
- Department of Sports Biochemistry, Faculty of Health and Sport Science, Doshisha University, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 610-0394, Japan
| | - Hideki Ohno
- Department of Molecular Predictive Medicine and Sport Science, Kyorin University, School of Medicine, 6-20-2 Shinkawa, Mitaka, Tokyo 181-8611, Japan
| |
Collapse
|
404
|
Mahé E, Reguiai Z, Barthelemy H, Quiles-Tsimaratos N, Chaby G, Girard C, Estève E, Maccari F, Descamps V, Schmutz JL, Begon E, Bravard P, Maillard H, Boyé T, Beauchet A, Sigal ML. Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study. J Eur Acad Dermatol Venereol 2012; 28:151-9. [PMID: 23279264 DOI: 10.1111/jdv.12066] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
BACKGROUND A significant weight gain has been reported in patients with psoriasis treated with anti-tumour necrosis factor-alpha agents. Among these patients, there are contradictory results about risk factors for weight gain. OBJECTIVE Assessing risk factors for weight increment in psoriatic patients on infliximab (IFX). METHODS This study was a 4-month, non-interventional, cross-sectional, multicentre study on adults with psoriasis performed in 19 French dermatological centres. All the patients who received IFX for at least 1 year were prospectively included, with retrospective analysis of data. Impact of sex, age, severity of the disease, cardiovascular and metabolic comorbidities, and previous and simultaneous systemic treatments on weight changes, was analysed. Weight gain was defined as an increment of more than 2% of baseline weight. RESULTS Overall, 191 psoriatic patients (males: 68.6%; mean age: 46.9 years) were included. Mean weight gain was 1.6 kg (2.1%) after 1 year of IFX. Half (48.2%) suffered from a weight gain, and 9.9% from a weight increment of 10% or more. Baseline weight and Body Mass Index, and cardiovascular and metabolic comorbidities did not influence weight. Men (P=0.007) and patients with severe psoriasis (BSA, P=0.005) had a tendency to put on weight. Patients with a hospital dietary follow-up (P=0.01; OR=0.36 [0.16-0.79]) and patients on methotrexate (P=0.03; OR=0.41 [0.18-0.93]) during IFX treatment are thinner, in a multivariate analysis. CONCLUSION Severe weight increment is frequent on IFX treatment, mainly in men, and patients with severe psoriasis. Dietary follow-up or simultaneous use of methotrexate could limit this weight increment.
Collapse
Affiliation(s)
- E Mahé
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - Z Reguiai
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - H Barthelemy
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - N Quiles-Tsimaratos
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - G Chaby
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - C Girard
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - E Estève
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - F Maccari
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - V Descamps
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - J-L Schmutz
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - E Begon
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - P Bravard
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - H Maillard
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - T Boyé
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - A Beauchet
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | - M-L Sigal
- Department of Dermatology, Hôpital Victor Dupouy, Argenteuil,Department of Dermatology, Centre Hospitalier Universitaire Robert Debré, Reims,Department of Dermatology, Centre Hospitalier d'Auxerre, Auxerre,Department of Dermatology, Hôpital Saint-Joseph, Marseille,Department of Dermatology, Hôpital Sud, Centre Hospitalier Universitaire d'Amiens, Picardie-Jules Verne University, Amiens,Department of Dermatology, Hôpital Saint-Eloi, Montpellier,Department of Dermatology, Centre Hospitalier Régional d'Orléans, Orléans,Department of Dermatology, Hôpital d'Instruction des Armées Bégin, Saint-Mandé,Department of Dermatology, Centre Hospitalier Universitaire Bichat-Claude Bernard, Paris 7 Diderot University, Assitance Publique-Hôpitaux de Paris, Paris,Department of Dermatology, Hôpitaux de Brabois, Vandœuvre les Nancy,Department of Dermatology, Centre Hospitalier de Pontoise, Pontoise,Department of Dermatology, Centre Hospitalier du Havres, Le Havres,Department of Dermatology, Centre Hospitalier du Mans, Le Mans,Department of Dermatology, Hôpital Sainte-Anne, Toulon, andDepartment of Public Health, Centre Hospitalier Universitaire Ambroise Paré, University of Versailles-Saint Quentin en Yvelines, Assistance Publique-Hôpitaux de Paris, Boulogne-Billancourt, France
| | | |
Collapse
|
405
|
Du B, Cawthorn WP, Su A, Doucette CR, Yao Y, Hemati N, Kampert S, McCoin C, Broome DT, Rosen CJ, Yang G, MacDougald OA. The transcription factor paired-related homeobox 1 (Prrx1) inhibits adipogenesis by activating transforming growth factor-β (TGFβ) signaling. J Biol Chem 2012; 288:3036-47. [PMID: 23250756 DOI: 10.1074/jbc.m112.440370] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
Differentiation of adipocytes from preadipocytes contributes to adipose tissue expansion in obesity. Impaired adipogenesis may underlie the development of metabolic diseases such as insulin resistance and type 2 diabetes. Mechanistically, a well defined transcriptional network coordinates adipocyte differentiation. The family of paired-related homeobox transcription factors, which includes Prrx1a, Prrx1b, and Prrx2, is implicated with regulation of mesenchymal cell fate, including myogenesis and skeletogenesis; however, whether these proteins impact adipogenesis remains to be addressed. In this study, we identify Prrx1a and Prrx1b as negative regulators of adipogenesis. We show that Prrx1a and Prrx1b are down-regulated during adipogenesis in vitro and in vivo. Stable knockdown of Prrx1a/b enhances adipogenesis, with increased expression of peroxisome proliferator-activated receptor-γ, CCAAT/enhancer-binding protein-α and FABP4 and increased secretion of the adipokines adiponectin and chemerin. Although stable low-level expression of Prrx1a, Prrx1b, or Prrx2 does not affect 3T3-L1 adipogenesis, transient overexpression of Prrx1a or Prrx1b inhibits peroxisome proliferator-activated receptor-γ activity. Prrx1 knockdown decreases expression of Tgfb2 and Tgfb3, and inhibition of TGFβ signaling during adipogenesis mimics the effects of Prrx1 knockdown. These data support the hypothesis that endogenous Prrx1 restrains adipogenesis by regulating expression of TGFβ ligands and thereby activating TGFβ signaling. Finally, we find that expression of Prrx1a or Prrx1b in adipose tissue increases during obesity and strongly correlates with Tgfb3 expression in BL6 mice. These observations suggest that increased Prrx1 expression may promote TGFβ activity in adipose tissue and thereby contribute to aberrant adipocyte function during obesity.
Collapse
Affiliation(s)
- Baowen Du
- College of Animal Science and Technology, Northwest Agriculture & Forestry University, Yangling, Shaanxi, 712100, China
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
406
|
Elton TS, Selemon H, Elton SM, Parinandi NL. Regulation of the MIR155 host gene in physiological and pathological processes. Gene 2012; 532:1-12. [PMID: 23246696 DOI: 10.1016/j.gene.2012.12.009] [Citation(s) in RCA: 356] [Impact Index Per Article: 29.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/06/2012] [Revised: 11/29/2012] [Accepted: 12/05/2012] [Indexed: 02/06/2023]
Abstract
MicroRNAs (miRNAs), a family of small nonprotein-coding RNAs, play a critical role in posttranscriptional gene regulation by acting as adaptors for the miRNA-induced silencing complex to inhibit gene expression by targeting mRNAs for translational repression and/or cleavage. miR-155-5p and miR-155-3p are processed from the B-cell Integration Cluster (BIC) gene (now designated, MIR155 host gene or MIR155HG). MiR-155-5p is highly expressed in both activated B- and T-cells and in monocytes/macrophages. MiR-155-5p is one of the best characterized miRNAs and recent data indicate that miR-155-5p plays a critical role in various physiological and pathological processes such as hematopoietic lineage differentiation, immunity, inflammation, viral infections, cancer, cardiovascular disease, and Down syndrome. In this review we summarize the mechanisms by which MIR155HG expression can be regulated. Given that the pathologies mediated by miR-155-5p result from the over-expression of this miRNA it may be possible to therapeutically attenuate miR-155-5p levels in the treatment of several pathological processes.
Collapse
Affiliation(s)
- Terry S Elton
- Davis Heart and Lung Research Institute, The Ohio State University, Columbus, OH, USA; College of Pharmacy, Division of Pharmacology, The Ohio State University, Columbus, OH, USA; Department of Medicine, Division of Cardiology, The Ohio State University, Columbus, OH, USA.
| | | | | | | |
Collapse
|
407
|
Gude MF, Frystyk J, Flyvbjerg A, Bruun JM, Richelsen B, Pedersen SB. The production and regulation of IGF and IGFBPs in human adipose tissue cultures. Growth Horm IGF Res 2012; 22:200-205. [PMID: 23079385 DOI: 10.1016/j.ghir.2012.09.004] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/08/2012] [Revised: 09/26/2012] [Accepted: 09/27/2012] [Indexed: 01/13/2023]
Abstract
BACKGROUND Adipocytes express and secrete IGFs and IGFBPs; proteins with important effects on adipocyte homeostasis. However, the factors that control adipocyte generation of IGFs and IGFBPs are not clarified. AIM To identify regulators of the synthesis of IGFs and IGFBs in adipose tissue. METHODS Subcutaneous adipose tissue fragments (500 mg) from 7 healthy lean women were incubated for 48 h following addition of GH (50 μg/l), dexamethasone (DXM, 20 nM), insulin (100 nM), interleukin (IL)-1β (50 ng/l), IL-6 (50 ng/l) and tumor-necrosis factor (TNF)-α (10 ng/l). Outcome parameters included tissue mRNA and culture media IGF and IGFBP levels. RESULTS Adipose tissue cultures secreted more IGF-II than IGF-I protein (1.14±0.41 vs. 0.26±0.09 μg/l [mean±SEM]; P<0.02). IGF-I mRNA and protein levels were stimulated by GH (to 340% [153; 477] (median [interquartiles]) and 270±26%, respectively; P<0.003), and inhibited by IL-1β (to 28% [21; 77] and 68±11%, respectively; P<0.003). TNF-α reduced IGF-I and IGF-II protein levels to 51±8% and 69±8%, respectively (P≤0.002), without affecting mRNA levels. IGF protein levels were unaffected by DXM, insulin and IL-6. All IGFBPs IGFBP-1 were expressed. IGFBP-4 was by far the most predominant IGFBP by immunoassay and WLB revealed two bands at 28 and 24 kDa, most likely representing glycosylated and non-glycosylated IGFBP-4. CONCLUSION Adipose tissue cultures secrete more IGF-II than IGF-I, and predominantly IGFBP-4. The secretion of IGF-I is affected by GH, IL-1β and TNF-α, whereas IGF-II is affected by TNF-α only. Hence, cytokines may control adipocyte homeostasis by affecting local IGF-generation.
Collapse
Affiliation(s)
- Mette Faurholdt Gude
- The Medical Research Laboratories, Institute of Clinical Medicine & Department of Endocrinology and Internal Medicine, Nørrebrogade, Aarhus University Hospital, DK-8000 Aarhus C, Denmark
| | | | | | | | | | | |
Collapse
|
408
|
Fukaya Y, Kuroda M, Aoyagi Y, Asada S, Kubota Y, Okamoto Y, Nakayama T, Saito Y, Satoh K, Bujo H. Platelet-rich plasma inhibits the apoptosis of highly adipogenic homogeneous preadipocytes in an in vitro culture system. Exp Mol Med 2012; 44:330-9. [PMID: 22314197 PMCID: PMC3366326 DOI: 10.3858/emm.2012.44.5.037] [Citation(s) in RCA: 33] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
Auto-transplantation of adipose tissue is commonly used for the treatment of tissue defects in plastic surgery. The survival of the transplanted adipose tissue is not always constant, and one of reasons is the accelerated apoptosis of the implanted preadipocytes. We have recently established highly homogeneous preadipocytes, named ccdPAs. The aim of the current study was to evaluate the regulation of the potency of platelet-rich plasma (PRP) on the apoptosis of ccdPAs in vitro. PRP stimulated the proliferation of the preadipocytes in a dose-dependent manner, and the stimulatory activity of 2% PRP was significantly higher than that of 2% FBS or 2% platelet-poor plasma (PPP). The presence of 2% PRP significantly inhibited serum starvation- or TNF-α/cycloheximide-induced apoptosis in comparison to 2% FBS or 2% PPP. DAPK1 and Bcl-2-interacting mediator of cell death (BIM) mRNAs were reduced in the preadipocytes cultured with 2% PRP in comparison to those cultured in 2% FBS. The gene expression levels were significantly higher in cells cultured without serum in comparison to cells cultured with 2% FBS, and the levels in the cells with 2% PRP were reduced to 5-10% of those in the cells without serum. These results indicated that ccdPAs exhibit anti- apoptotic activities, in addition to increased proliferation, when cultured in 2% PRP in comparison to the same concentration of FBS, and that this was accompanied with reduced levels of DAPK1 and BIM mRNA expression in in vitro culture. PRP may improve the outcome of transplantation of adipose tissue by enhancing the anti-apoptotic activities of the implanted preadipocytes.
Collapse
Affiliation(s)
- Yoshitaka Fukaya
- Department of Plastic and Reconstructive Surgery, Graduate School of Medicine, Chiba University, Chiba 260-0856, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
409
|
Lim WS, Ng DL, Kor SB, Wong HK, Tengku-Muhammad TS, Choo QC, Chew CH. Tumour necrosis factor alpha down-regulates the expression of peroxisome proliferator activated receptor alpha (PPARα) in human hepatocarcinoma HepG2 cells by activation of NF-κB pathway. Cytokine 2012; 61:266-74. [PMID: 23141142 DOI: 10.1016/j.cyto.2012.10.007] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/23/2012] [Revised: 09/27/2012] [Accepted: 10/10/2012] [Indexed: 01/17/2023]
Abstract
Peroxisome proliferator activated receptor-alpha (PPARα) plays a major role in the regulation of lipid and glucose homeostasis, and inflammatory responses. The objectives of the study were to systematically investigate the effects of TNF-α and its regulatory pathway on PPARα expression in HepG2 cells using Real-Time RT-PCR and western blot analysis. Here, TNF-α suppressed PPARα mRNA expression in a dose- and time-dependent manner at the level of gene transcription. Pre-treatment of cells with 10μM of Wedelolactone for 2h was sufficient to restore PPARα expression to basal levels and also affected the expression of PPARα-regulated genes. This study also demonstrated that TNF-α represses PPARα expression by augmenting the activity of canonical NF-κB signalling pathway. This was shown by the abrogation of TNF-α-mediated PPARα down-regulation, after both p65 and p50 were knocked down via siRNA. The IKK contributes to IκBα degradation and mediates inducible phosphorylation of p105 at Ser933. Surprisingly, phosphorylation of p65 at Ser468 and Ser536 were severely abrogated with Wedelolactone inhibition, suggesting that Ser468 and Ser536, but not Ser276, may mediate the TNF-α inhibitory action on PPARα gene expression. These results suggest that TNF-α might, at least in part, suppress PPARα expression through activation of IKK/p50/p105/p65 pathway. Furthermore, phosphorylation of p65 at Ser468 and Ser536 may play a crucial role in the mechanism that limits PPARα production in the human HepG2 cells.
Collapse
Affiliation(s)
- Wyi Sian Lim
- Department of Biomedical Science, Faculty of Science, Universiti Tunku Abdul Rahman, Bandar Barat, 31900 Kampar, Perak, Malaysia
| | | | | | | | | | | | | |
Collapse
|
410
|
Lee MJ, Fried SK. Glucocorticoids antagonize tumor necrosis factor-α-stimulated lipolysis and resistance to the antilipolytic effect of insulin in human adipocytes. Am J Physiol Endocrinol Metab 2012; 303:E1126-33. [PMID: 22949029 PMCID: PMC3492859 DOI: 10.1152/ajpendo.00228.2012] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
High concentrations of TNF within obese adipose tissue increase basal lipolysis and antagonize insulin signaling. Adipocytes of the obese are also exposed to elevated levels of glucocorticoids (GCs), which antagonize TNF actions in many cell types. We tested the hypothesis that TNF decreases sensitivity to the antilipolytic effect of insulin and that GCs antagonize this effect in differentiated human adipocytes. Lipolysis and expression levels of lipolytic proteins were measured after treating adipocytes with TNF, dexamethasone (DEX), or DEX + TNF for up to 48 h. TNF not only increased basal lipolysis, it caused resistance to the antilipolytic effects of insulin in human adipocytes. DEX alone did not significantly affect lipolysis. Cotreatment with DEX blocked TNF induction of basal lipolysis and insulin resistance by antagonizing TNF stimulation of PKA-mediated phosphorylation of hormone-sensitive lipase (HSL) at Ser⁵⁶³ and Ser⁶⁶⁰ and perilipin. TNF did not affect perilipin, HSL, or phosphodiesterase-3B mass but paradoxically suppressed adipose tissue triglyceride lipase expression, and this effect was blocked by DEX. The extent to which GCs can restrain the lipolytic actions of TNF may both diminish the potentially deleterious effects of excess lipolysis and contribute to fat accumulation in obesity.
Collapse
Affiliation(s)
- Mi-Jeong Lee
- Section of Endocrinology, Diabetes, and Nutrition, Department of Medicine, Boston University, Boston, Massachusetts, USA.
| | | |
Collapse
|
411
|
Gochberg-Sarver A, Kedmi M, Gana-Weisz M, Bar-Shira A, Orr-Urtreger A. Tnfα, Cox2 and AdipoQ adipokine gene expression levels are modulated in murine adipose tissues by both nicotine and nACh receptors containing the β2 subunit. Mol Genet Metab 2012; 107:561-70. [PMID: 22926197 DOI: 10.1016/j.ymgme.2012.08.012] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/08/2012] [Accepted: 08/08/2012] [Indexed: 12/24/2022]
Abstract
Studies have provided evidences for the effects of nicotine on adipose tissues, as well as in inflammatory response. We hypothesized that nicotine affects adipokine gene expression in adipose tissues via specific neuronal nicotinic acetylcholine receptors (nAChRs). First, we described the expression of multiple nAChR subunit genes in mouse white and brown adipose tissues (WAT and BAT), and detected differential expression in WAT and BAT (α2>α5>β2 and α2>β2>β4, respectively). Additionally, when nicotine was administered to wild-type mice, it significantly affected the expression of adipokine genes, such as Tnfα, AdipoQ, Haptoglobin and Mcp1 in WAT. Next, we demonstrated that in mice deficient for the β2 nAChR subunit (β2-/- mice), the expression levels of Cox2 and Ngfβ genes in WAT, and Leptin, Cox2, AdipoQ and Haptoglobin in BAT, were significantly altered. Furthermore, interactions between mouse β2 subunit and nicotine treatment affected the expression levels of the adipokine genes Tnfα, Cox2 and AdipoQ in WAT and of AdipoQ in BAT. Finally, analysis of a cellular model of cultured adipocytes demonstrated that application of nicotine after silencing of the β2 nAChR subunit significantly elevated the expression level of Cox2 gene. Together, our data suggest a molecular link between the β2 nACh receptor subunit and the expression levels of specific adipokines, which is also affected by nicotine.
Collapse
|
412
|
Wang X, Huang M, Wang Y. The effect of insulin, TNFα and DHA on the proliferation, differentiation and lipolysis of preadipocytes isolated from large yellow croaker (Pseudosciaena Crocea R.). PLoS One 2012; 7:e48069. [PMID: 23110176 PMCID: PMC3482209 DOI: 10.1371/journal.pone.0048069] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/22/2012] [Accepted: 09/20/2012] [Indexed: 01/19/2023] Open
Abstract
Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNFα and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNFα and DHA inhibited cell proliferation and differentiation. While TNFα stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor α, γ (PPARα, PPARγ) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNFα and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.
Collapse
Affiliation(s)
- Xinxia Wang
- Institute of Feed Science, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China
| | - Ming Huang
- Institute of Feed Science, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China
| | - Yizhen Wang
- Institute of Feed Science, Zhejiang University, Hangzhou, Zhejiang Province, People’s Republic of China
- * E-mail:
| |
Collapse
|
413
|
Ramsay TG, Stoll MJ, Conde-Aguilera JA, Caperna TJ. Peripheral tumor necrosis factor α regulation of adipose tissue metabolism and adipokine gene expression in neonatal pigs. Vet Res Commun 2012; 37:1-10. [PMID: 23090779 DOI: 10.1007/s11259-012-9540-z] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/04/2012] [Indexed: 01/21/2023]
Abstract
The neonatal pig is susceptible to stress and infection, conditions which favor tumor necrosis factor α (TNFα) secretion. This study examined whether TNFα can alter metabolic activity and cytokine gene expression within neonatal pig adipose tissue. Cell cultures were prepared from neonatal subcutaneous adipose tissue using standard procedures. Cultures (5 experiments) were incubated with medium containing (14)C-glucose for 4 h to measure glucose conversion to lipid in the presence of combinations of TNFα (10 ng), insulin (10 nM) and an anti-pig TNFα antibody (5 μg). Basal lipogenesis was not affected by TNFα treatment (P > 0.05). However, insulin stimulated lipogenesis was reduced by TNFα (P < 0.02). For gene expression studies, cultures were incubated with 0, 2.5, 5.0 or 10 ng TNFα for 2, 4 or 24 h (n = 4 experiments). Interleukin 6 and TNFα gene expression were acutely (2-4 h) stimulated by exogenous TNFα treatment (P < 0.05), as analyzed by real-time PCR. Adiponectin mRNA abundance was reduced (P < 0.001) while monocyte chemotactic gene expression was increased by TNFα treatment at all time points (P < 0.001). Chronic treatment (24 h) was required to increase monocyte multiplication inhibitory factor or suppress lipoprotein lipase gene expression (P < 0.02). These data suggest conditions which increase serum TNFα, like sepsis, could suppress lipid accumulation within adipose tissue at a time of critical need in the neonate and induce a variety of adipose derived cytokines which may function to alter adipose physiology.
Collapse
Affiliation(s)
- T G Ramsay
- Animal Biosciences and Biotechnology Laboratory, Beltsville Agricultural Research Center, USDA/ARS, BARC-East, Beltsville, MD 20705, USA.
| | | | | | | |
Collapse
|
414
|
Marcotorchino J, Gouranton E, Romier B, Tourniaire F, Astier J, Malezet C, Amiot MJ, Landrier JF. Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol Nutr Food Res 2012; 56:1771-82. [PMID: 23065818 DOI: 10.1002/mnfr.201200383] [Citation(s) in RCA: 109] [Impact Index Per Article: 9.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/19/2012] [Revised: 09/05/2012] [Accepted: 09/06/2012] [Indexed: 12/19/2022]
Abstract
SCOPE Obesity is strongly associated with low-grade inflammation, notably due to an overproduction of proinflammatory markers by adipose tissue and adipocytes as well as a vitamin D deficiency. Whether these problems are interrelated has not been clearly established. METHODS AND RESULTS In the present report, decreases in the levels of inflammatory markers such as IL-6, MCP-1, and IL-1β (mRNA and protein level) in human adipocytes and in 3T3-L1 adipocytes were observed after 1,25-dihydroxyvitamin D3 (1,25-(OH)(2) D(3) ) treatment. Such treatment also decreased the expression of the TNF-α-mediated proinflammatory marker in 3T3-L1 and human adipocytes. A similar effect was observed in adipocyte-macrophage co-culture systems in which 1,25-(OH)(2) D(3) decreased proinflammatory marker expression under basal and TNF-α-stimulated conditions. The involvement of VDR and NF-κB was confirmed in these regulations. Incubation with 1,25-(OH)(2) D(3) also resulted in the dephosphorylation of p38, which is linked to the transcriptional induction of several Dusp family members. Functional consequences of the 1,25-(OH)(2) D(3) treatment on glucose uptake and AKT phosphorylation were observed. CONCLUSION The improvement of both proinflammatory status and glucose uptake in adipocytes under 1,25-(OH)(2) D(3) effect suggests that low-grade inflammation could be linked to vitamin D deficiency. This observation offers new perspectives in the context of obesity and associated physiopathological disorders.
Collapse
|
415
|
Variation pondérale chez les patients recevant un traitement systémique pour un psoriasis. Ann Dermatol Venereol 2012; 139:649-51. [DOI: 10.1016/j.annder.2012.06.032] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2012] [Revised: 06/20/2012] [Accepted: 06/28/2012] [Indexed: 11/22/2022]
|
416
|
Jia T, Carrero JJ, Lindholm B, Stenvinkel P. The complex role of adiponectin in chronic kidney disease. Biochimie 2012; 94:2150-6. [DOI: 10.1016/j.biochi.2012.02.024] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/31/2011] [Accepted: 02/17/2012] [Indexed: 12/25/2022]
|
417
|
Heckmann BL, Zhang X, Xie X, Liu J. The G0/G1 switch gene 2 (G0S2): regulating metabolism and beyond. Biochim Biophys Acta Mol Cell Biol Lipids 2012; 1831:276-81. [PMID: 23032787 DOI: 10.1016/j.bbalip.2012.09.016] [Citation(s) in RCA: 81] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/16/2012] [Revised: 09/24/2012] [Accepted: 09/26/2012] [Indexed: 02/06/2023]
Abstract
The G0/G1 switch gene 2 (G0S2) was originally identified in blood mononuclear cells following induced cell cycle progression. Translation of G0S2 results in a small basic protein of 103 amino acids in size. It was initially believed that G0S2 mediates re-entry of cells from the G0 to G1 phase of the cell cycle. Recent studies have begun to reveal the functional aspects of G0S2 and its protein product in various cellular settings. To date the best-known function of G0S2 is its direct inhibitory capacity on the rate-limiting lipolytic enzyme adipose triglyceride lipase (ATGL). Other studies have illustrated key features of G0S2 including sub-cellular localization, expression profiles and regulation, and possible functions in cellular proliferation and differentiation. In this review we present the current knowledge base regarding all facets of G0S2, and pose a variety of questions and hypotheses pertaining to future research directions.
Collapse
Affiliation(s)
- Bradlee L Heckmann
- Department of Biochemistry & Molecular Biology, Mayo Clinic, Scottsdale, Arizona 85259, USA
| | | | | | | |
Collapse
|
418
|
Zhu M, Williams AS, Chen L, Wurmbrand AP, Williams ES, Shore SA. Role of TNFR1 in the innate airway hyperresponsiveness of obese mice. J Appl Physiol (1985) 2012; 113:1476-85. [PMID: 22984249 DOI: 10.1152/japplphysiol.00588.2012] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023] Open
Abstract
The purpose of this study was to examine the role of tumor necrosis factor receptor 1 (TNFR1) in the airway hyperresponsiveness characteristic of obese mice. Airway responsiveness to intravenous methacholine was measured using the forced oscillation technique in obese Cpe(fat) mice that were either sufficient or genetically deficient in TNFR1 (Cpe(fat) and Cpe(fat)/TNFR1(-/-) mice) and in lean mice that were either sufficient or genetically deficient in TNFR1 [wild-type (WT) and TNFR1(-/-) mice]. Compared with lean WT mice, Cpe(fat) mice exhibited airway hyperresponsiveness. Airway hyperresponsives was also greater in Cpe(fat)/TNFR1(-/-) than in Cpe(fat) mice. Compared with WT mice, Cpe(fat) mice had increases in bronchoalveolar lavage fluid concentrations of several inflammatory moieties including eotaxin, IL-9, IP-10, KC, MIG, and VEGF. These factors were also significantly elevated in Cpe(fat)/TNFR1(-/-) vs. TNFR1(-/-) mice. Additional moieties including IL-13 were also elevated in Cpe(fat)/TNFR1(-/-) vs. TNFR1(-/-) mice but not in Cpe(fat) vs. WT mice. IL-17A mRNA expression was greater in Cpe(fat)/TNFR1(-/-) vs. Cpe(fat) mice and in TNFR1(-/-) vs. WT mice. Analysis of serum indicated that obesity resulted in systemic as well as pulmonary inflammation, but TNFR1 deficiency had little effect on this systemic inflammation. Our results indicate that TNFR1 is protective against the airway hyperresponsiveness associated with obesity and suggest that effects on pulmonary inflammation may be contributing to this protection.
Collapse
Affiliation(s)
- Ming Zhu
- Department of Environmental Health, Harvard School of Public Health, Boston, Massachusetts 02115, USA
| | | | | | | | | | | |
Collapse
|
419
|
Vidal F, Domingo P, Viladés C, Peraire J, Arnedo M, Alcamí J, Leal M, Villarroya F, Gatell JM. Pharmacogenetics of the lipodystrophy syndrome associated with HIV infection and combination antiretroviral therapy. Expert Opin Drug Metab Toxicol 2012; 7:1365-82. [PMID: 21999362 DOI: 10.1517/17425255.2011.621941] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/15/2022]
Abstract
INTRODUCTION Antiretroviral drugs have been associated with several toxicities that limit their success. Of the chronic toxicities, the lipodystrophy syndrome is of special concern due to the metabolic alterations that can accompany it. Why some patients treated with a particular antiretroviral regimen develop lipodystrophy, while others do not, is a medical mystery, but it has been suggested that individuals may (or may not) have a genetically conditioned predisposition. Pharmacogenetics is the science that studies how the genetic composition of individuals can give rise to interindividual variations in response to drugs and drug toxicity. AREAS COVERED This article reviews the published investigations on the association between host genetic determinants in treated HIV-infected patients and the presence of lipodystrophy. Studies were identified through a PubMed database search. Case-control and longitudinal studies into pharmacogenetic association were selected. Areas covered include the data on the genetic variants of mitochondrial parameters, cytokines, adipokines, proteins involved in adipocyte biology and proteins involved in stavudine metabolism. EXPERT OPINION Most studies provide inconsistent data due to partial genetic evaluation, different assessment of lipodystrophy and low number of patients evaluated. The pharmacogenetics of lipodystrophy in HIV-infected patients treated with antiretroviral drugs still belongs in the research laboratory.
Collapse
Affiliation(s)
- Francesc Vidal
- Infectious Diseases and HIV/AIDS Section, Department of Internal Medicine , Hospital Universitari de Tarragona Joan XXIII, IISPV, Universitat Rovira i Virgili, Tarragona, Spain.
| | | | | | | | | | | | | | | | | |
Collapse
|
420
|
Schipper HS, Prakken B, Kalkhoven E, Boes M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol Metab 2012; 23:407-15. [PMID: 22795937 DOI: 10.1016/j.tem.2012.05.011] [Citation(s) in RCA: 211] [Impact Index Per Article: 17.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/16/2012] [Revised: 05/29/2012] [Accepted: 05/31/2012] [Indexed: 12/20/2022]
Abstract
Adipose tissue (AT) plays a pivotal role in whole-body lipid and glucose homeostasis. AT exerts metabolic control through various immunological mechanisms that instigated a new research field termed immunometabolism. Here, we review AT-resident immune cells and their role as key players in immunometabolism. In lean subjects, AT-resident immune cells have housekeeping functions ranging from apoptotic cell clearance to extracellular matrix remodeling and angiogenesis. However, obesity provides bacterial and metabolic danger signals that mimic bacterial infection, and drives a shift in immune-cell phenotypes and numbers, classified as a prototypic T helper 1 (Th1) inflammatory response. The resulting AT inflammation and insulin resistance link obesity to its metabolic sequel, and suggests that targeted immunomodulatory interventions may be beneficial for obese patients.
Collapse
Affiliation(s)
- Henk S Schipper
- Department of Pediatric Immunology and Infectious Diseases, University Medical Center Utrecht and Center for Molecular and Cellular Intervention, Wilhelmina Children's Hospital, Utrecht, The Netherlands
| | | | | | | |
Collapse
|
421
|
Abstract
Nonalcoholic fatty liver disease is becoming an epidemic. Fat is typically stored in adipose tissue in the form of triglycerides (TGs). The deposition of TGs in the liver is the result of an imbalance between the amount of energy taken in and the amount used. This balance is maintained by a complex interplay between the dietary intake of nutrients, the hormonal response to the nutrients, and their effect on both the liver and adipose tissue. Disruption of this system is what leads to the development of steatosis and is the focus of this article.
Collapse
Affiliation(s)
- Scott C Matherly
- Division of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, Virginia Commonwealth University Medical Center, Richmond, 23298, USA
| | | |
Collapse
|
422
|
Ren G, Kim JY, Smas CM. Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolism. Am J Physiol Endocrinol Metab 2012; 303:E334-51. [PMID: 22569073 PMCID: PMC3423120 DOI: 10.1152/ajpendo.00084.2012] [Citation(s) in RCA: 224] [Impact Index Per Article: 18.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/08/2023]
Abstract
To identify new genes that are important in fat metabolism, we utilized the Lexicon-Genentech knockout database of genes encoding transmembrane and secreted factors and whole murine genome transcriptional profiling data that we generated for 3T3-L1 in vitro adipogenesis. Cross-referencing null models evidencing metabolic phenotypes with genes induced in adipogenesis led to identification of a new gene, which we named RIFL (refeeding induced fat and liver). RIFL-null mice have serum triglyceride levels approximately one-third of wild type. RIFL transcript is induced >100-fold during 3T3-L1 adipogenesis and is also increased markedly during adipogenesis of murine and human primary preadipocytes. siRNA-mediated knockdown of RIFL during 3T3-L1 adipogenesis results in an ~35% decrease in adipocyte triglyceride content. Murine RIFL transcript is highly enriched in white and brown adipose tissue and liver. Fractionation of WAT reveals that RIFL transcript is exclusive to adipocytes with a lack of expression in stromal-vascular cells. Nutritional and hormonal studies are consistent with a prolipogenic function for RIFL. There is evidence of an approximately eightfold increase in RIFL transcript level in WAT in ob/ob mice compared with wild-type mice. RIFL transcript level in WAT and liver is increased ~80- and 12-fold, respectively, following refeeding of fasted mice. Treatment of 3T3-L1 adipocytes with insulin increases RIFL transcript ≤35-fold, whereas agents that stimulate lipolysis downregulate RIFL. Interestingly, the 198-amino acid RIFL protein is predicted to be secreted and shows ~30% overall conservation with the NH(2)-terminal half of angiopoietin-like 3, a liver-secreted protein that impacts lipid metabolism. In summary, our data suggest that RIFL is an important new regulator of lipid metabolism.
Collapse
Affiliation(s)
- Gang Ren
- Department of Biochemistry and Cancer Biology and Center for Diabetes and Endocrine Research, University of Toledo College of Medicine, Toledo, OH 43614, USA
| | | | | |
Collapse
|
423
|
Potential effects of lignan-enriched flaxseed powder on bodyweight, visceral fat, lipid profile, and blood pressure in rats. Fitoterapia 2012; 83:941-6. [DOI: 10.1016/j.fitote.2012.04.010] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2012] [Revised: 04/09/2012] [Accepted: 04/10/2012] [Indexed: 11/22/2022]
|
424
|
Involvement of protein tyrosine phosphatases and inflammation in hypothalamic insulin resistance associated with ageing: effect of caloric restriction. Mech Ageing Dev 2012; 133:489-97. [PMID: 22733037 DOI: 10.1016/j.mad.2012.06.001] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/17/2012] [Revised: 05/17/2012] [Accepted: 06/04/2012] [Indexed: 12/13/2022]
Abstract
Aged Wistar rats present central insulin resistance associated with ageing. Several steps of the insulin signaling pathway have been described to be impaired in aged rats at hypothalamic level. In the present article we have explored possible alterations in protein tyrosine phosphatases (PTPs) involved in insulin receptor dephosphorylation, as well as pro-inflammatory pathways and serine kinases such as inhibitory kappa β kinase-nuclear factor kappa-B (IKKβ-NFκB), p38 mitogen-activated protein kinase (p38) and protein kinase C θ (PKCθ) that may also be involved in the decreased insulin signaling during ageing. We detected that ageing brings about a specific increase in insulin receptor tyrosine phosphatase activity and PTP1B serine phosphorylation. Increased association of PTP1B and leukocyte common antigen-related tyrosine protein phosphatase (LAR) with insulin receptor was also observed in hypothalamus from aged rats. Besides these mechanisms, increased activation of the IKKβ-NFκB pathway, p38 and PKCθ serine/threonine kinases were also detected. These data contribute to explain the hypothalamic insulin resistance associated with ageing. Caloric restriction ameliorates most of the effects of ageing on the above mentioned increases in PTPs and serine/threonine kinases activities and points to age-associated adiposity and inflammation as key factors in the development of age-associated insulin resistance.
Collapse
|
425
|
Mourad AA, Heeba GH, Taye A, El-Moselhy MA. Comparative study between atorvastatin and losartan on high fat diet-induced type 2 diabetes mellitus in rats. Fundam Clin Pharmacol 2012; 27:489-97. [DOI: 10.1111/j.1472-8206.2012.01048.x] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2012] [Revised: 04/21/2012] [Accepted: 05/10/2012] [Indexed: 12/24/2022]
Affiliation(s)
- Ahmed A. Mourad
- Department of Pharmacology and Toxicology, Faculty of Pharmacy; Minia University; El-Minia; Egypt
| | - Gehan H. Heeba
- Department of Pharmacology and Toxicology, Faculty of Pharmacy; Minia University; El-Minia; Egypt
| | - Ashraf Taye
- Department of Pharmacology and Toxicology, Faculty of Pharmacy; Minia University; El-Minia; Egypt
| | - Mohamed A. El-Moselhy
- Department of Pharmacology and Toxicology, Faculty of Pharmacy; Minia University; El-Minia; Egypt
| |
Collapse
|
426
|
Role of MHC-linked susceptibility genes in the pathogenesis of human and murine lupus. Clin Dev Immunol 2012; 2012:584374. [PMID: 22761632 PMCID: PMC3385965 DOI: 10.1155/2012/584374] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2012] [Accepted: 05/07/2012] [Indexed: 02/08/2023]
Abstract
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by the production of autoantibodies against nuclear antigens and a systemic inflammation that can damage a broad spectrum of organs. SLE patients suffer from a wide variety of symptoms, which can affect virtually almost any tissue. As lupus is difficult to diagnose, the worldwide prevalence of SLE can only be roughly estimated to range from 10 and 200 cases per 100,000 individuals with dramatic differences depending on gender, ethnicity, and location. Although the treatment of this disease has been significantly ameliorated by new therapies, improved conventional drug therapy options, and a trained expert eye, the underlying pathogenesis of lupus still remain widely unknown. The complex etiology reflects the complex genetic background of the disease, which is also not well understood yet. However, in the past few years advances in lupus genetics have been made, notably with the publication of genome-wide association studies (GWAS) in humans and the identification of susceptibility genes and loci in mice. This paper reviews the role of MHC-linked susceptibility genes in the pathogenesis of systemic lupus erythematosus.
Collapse
|
427
|
Lin L, Pang W, Chen K, Wang F, Gengler J, Sun Y, Tong Q. Adipocyte expression of PU.1 transcription factor causes insulin resistance through upregulation of inflammatory cytokine gene expression and ROS production. Am J Physiol Endocrinol Metab 2012; 302:E1550-9. [PMID: 22454293 PMCID: PMC3378156 DOI: 10.1152/ajpendo.00462.2011] [Citation(s) in RCA: 41] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
We have reported previously that ETS family transcription factor PU.1 is expressed in mature adipocytes of white adipose tissue. PU.1 expression is increased greatly in mouse models of genetic or diet-induced obesity. Here, we show that PU.1 expression is increased only in visceral but not subcutaneous adipose tissues of obese mice, and the adipocytes are responsible for this increase in PU.1 expression. To further address PU.1's physiological function in mature adipocytes, PU.1 was knocked down in 3T3-L1 cells using retroviral-mediated expression of PU.1-targeting shRNA. Consistent with previous findings that PU.1 regulates its target genes, such as NADPH oxidase subunits and proinflammatory cytokines in myeloid cells, the mRNA levels of proinflammatory cytokines (TNFα, IL-1β, and IL-6) and cytosolic components of NADPH oxidase (p47phox and p40phox) were downregulated significantly in PU.1-silenced adipocytes. NADPH oxidase is a main source for reactive oxygen species (ROS) generation. Indeed, silencing PU.1 suppressed NADPH oxidase activity and attenuated ROS in basal or hydrogen peroxide-treated adipocytes. Silencing PU.1 in adipocytes suppressed JNK1 activation and IRS-1 phosphorylation at Ser(307). Consequently, PU.1 knockdown improved insulin signaling and increased glucose uptake in basal and insulin-stimulated conditions. Furthermore, knocking down PU.1 suppressed basal lipolysis but activated stimulated lipolysis. Collectively, these findings indicate that obesity induces PU.1 expression in adipocytes to upregulate the production of ROS and proinflammatory cytokines, both of which lead to JNK1 activation, insulin resistance, and dysregulation of lipolysis. Therefore, PU.1 might be a mediator for obesity-induced adipose inflammation and insulin resistance.
Collapse
Affiliation(s)
- Ligen Lin
- US Department of Agriculture/Agricultural Research Service Children's Nutrition Research Center, Houston, Texas, USA
| | | | | | | | | | | | | |
Collapse
|
428
|
Xu Q, Huang L, Liu J, Ma L, Chen T, Chen J, Peng F, Cao D, Yang Z, Qiu N, Qiu J, Wang G, Liang X, Peng A, Xiang M, Wei Y, Chen L. Design, synthesis and biological evaluation of thiazole- and indole-based derivatives for the treatment of type II diabetes. Eur J Med Chem 2012; 52:70-81. [DOI: 10.1016/j.ejmech.2012.03.006] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/25/2011] [Revised: 02/29/2012] [Accepted: 03/02/2012] [Indexed: 01/22/2023]
|
429
|
Chin CH, Tsai FC, Chen SP, Wang KC, Chang CC, Pai MH, Fong TH. YC-1, a potent antithrombotic agent, induces lipolysis through the PKA pathway in rat visceral fat cells. Eur J Pharmacol 2012; 689:1-7. [PMID: 22659114 DOI: 10.1016/j.ejphar.2012.05.013] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2012] [Revised: 04/26/2012] [Accepted: 05/15/2012] [Indexed: 10/28/2022]
Abstract
This study investigated the effects of 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1), a soluble guanylyl cyclase (sGC) activator and potential antithrombotic agent, on lipolysis in isolated visceral fat cells of the rat. Visceral fat cells were isolated from epididymal fat pads of rats and treated with YC-1 at different doses and times. Glycerol release, and intracellular cAMP and cGMP levels were analyzed by specific kits. Moreover, several inhibitors or drugs were used to examine the signal transduction pathways of YC-1-induced lipolysis in adipocytes. Herein we report that YC-1 stimulated glycerol release in dose- and time-dependent manners. Intracellular cAMP and cGMP levels of adipocytes both increased in time-dependent manners, but elevation of the cGMP level was faster and higher than that of the cAMP level after YC-1 treatment. An sGC inhibitor (ODQ) inhibited YC-1-induced glycerol release, indicating the involvement of sGC in YC-1-induced lipolysis. Administration of insulin, an activator of type-3B phosphodiesterase (PDE-3B), attenuated YC-1-induced lipolysis, indicating that elevation of the cAMP level is an important step in the lipolytic effect of YC-1. In addition, YC-1-induced lipolysis was inhibited by a protein kinase A (PKA) inhibitor (KT5720) but not by a PKG inhibitor (KT5823), indicating that YC-1-induced lipolysis occurs through a PKA-dependent pathway. A Western blot analysis showed that extracellular signal-regulated kinase was not phosphorylated by YC-1 treatment. In conclusion, our results suggest that YC-1 might stimulate lipolysis via activation of sGC/cGMP and then activation of the cAMP/PKA signaling cascade in isolated rat visceral adipocytes.
Collapse
Affiliation(s)
- Chih-Hui Chin
- Institute of Cardiovascular Medicine, Cathay General Hospital, Taipei 10630, Taiwan
| | | | | | | | | | | | | |
Collapse
|
430
|
Resveratrol prevents TNFα-induced suppression of adiponectin expression via PPARγ activation in 3T3-L1 adipocytes. Clin Exp Med 2012; 13:193-9. [DOI: 10.1007/s10238-012-0189-2] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2012] [Accepted: 04/28/2012] [Indexed: 12/18/2022]
|
431
|
Cai D, Li H, Zhou B, Han L, Zhang X, Yang G, Yang G. Conjugated linoleic acid supplementation caused reduction of perilipin1 and aberrant lipolysis in epididymal adipose tissue. Biochem Biophys Res Commun 2012; 422:621-6. [PMID: 22609209 DOI: 10.1016/j.bbrc.2012.05.038] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2012] [Accepted: 05/09/2012] [Indexed: 11/18/2022]
Abstract
Perilipin1, a coat protein of lipid droplet, plays a key role in adipocyte lipolysis and fat formation of adipose tissues. However, it is not clear how the expression of perilipin1 is affected in the decreased white adipose tissues (WAT) of mice treated with dietary supplement of conjugated linoleic acids (CLA). Here we obtained lipodystrophic mice by dietary administration of CLA which exhibited reduced epididymal (EPI) WAT, aberrant adipocytes and decreased expression of leptin in this tissue. We found both transcription and translation of perilipin1 was suppressed significantly in EPI WAT of CLA-treated mice compared to that of control mice. The gene expression of negative regulator tumor necrosis factor α (TNFα) and the positive regulator Peroxisome Proliferator-Activated Receptor-γ (PPARγ) of perilipin1 was up-regulated and down-regulated, respectively. In cultured 3T3-L1 cells the promoter activity of perilipin1 was dramatically inhibited in the presence of CLA. Using ex vivo experiment we found that the basal lipolysis was elevated but the hormone-stimulated lipolysis blunted in adipose explants of CLA-treated mice compared to that of control mice, suggesting that the reduction of perilipin1 in white adipose tissues may at least in part contribute to CLA-mediated alternation of lipolysis of WAT.
Collapse
Affiliation(s)
- Demin Cai
- College of Animal Sciences and Veterinary Medicine, Henan Agricultural University, Zhengzhou 450002, Henan Province, People's Republic of China
| | | | | | | | | | | | | |
Collapse
|
432
|
Salles J, Tardif N, Landrier JF, Mothe-Satney I, Guillet C, Boue-Vaysse C, Combaret L, Giraudet C, Patrac V, Bertrand-Michel J, Denis P, Chardigny JM, Boirie Y, Walrand S. TNFα gene knockout differentially affects lipid deposition in liver and skeletal muscle of high-fat-diet mice. J Nutr Biochem 2012; 23:1685-93. [PMID: 22464148 DOI: 10.1016/j.jnutbio.2011.12.001] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/31/2011] [Revised: 12/01/2011] [Accepted: 12/02/2011] [Indexed: 12/31/2022]
Abstract
AIMS/HYPOTHESIS Inflammation and ectopic lipid deposition contribute to obesity-related insulin resistance (IR). Studies have shown that deficiency of the proinflammatory cytokine tumor necrosis factor-α (TNFα) protects against the IR induced by a high-fat diet (HFD). We aimed to evaluate the relationship between HFD-related inflammation and lipid deposition in skeletal muscle and liver. EXPERIMENTAL DESIGN Wild-type (WT) and TNFα-deficient (TNFα-KO) mice were subjected to an HFD for 12 weeks. A glucose tolerance test was performed to evaluate IR. Inflammatory status was assessed by measuring plasma and tissue transcript levels of cytokines. Lipid intermediate concentrations were measured in plasma, muscle and liver. The expression of genes involved in fatty acid transport, synthesis and oxidation was analyzed in adipose tissue, muscle and liver. RESULTS HFD induced a higher body weight gain in TNFα-KO mice than in WT mice. The weight of epididymal and abdominal adipose tissues was twofold lower in WT mice than in TNFα-KO mice, whereas liver weight was significantly heavier in WT mice. IR, systemic and adipose tissue inflammation, and plasma nonesterified fatty acid levels were reduced in TNFα-KO mice fed an HFD. TNFα deficiency improved fatty acid metabolism and had a protective effect against lipid deposition, inflammation and fibrosis associated with HFD in liver but had no impact on these markers in muscle. CONCLUSIONS Our data suggest that in an HFD context, TNFα deficiency reduced hepatic lipid accumulation through two mechanisms: an increase in adipose tissue storage capacity and a decrease in fatty acid uptake and synthesis in the liver.
Collapse
Affiliation(s)
- Jérôme Salles
- INRA, UMR 1019, UNH, CRNH Auvergne, F-63000 Clermont-Ferrand, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
433
|
Lam YY, Ha CWY, Campbell CR, Mitchell AJ, Dinudom A, Oscarsson J, Cook DI, Hunt NH, Caterson ID, Holmes AJ, Storlien LH. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS One 2012; 7:e34233. [PMID: 22457829 PMCID: PMC3311621 DOI: 10.1371/journal.pone.0034233] [Citation(s) in RCA: 435] [Impact Index Per Article: 36.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/21/2011] [Accepted: 02/24/2012] [Indexed: 02/06/2023] Open
Abstract
We investigated the relationship between gut health, visceral fat dysfunction and metabolic disorders in diet-induced obesity. C57BL/6J mice were fed control or high saturated fat diet (HFD). Circulating glucose, insulin and inflammatory markers were measured. Proximal colon barrier function was assessed by measuring transepithelial resistance and mRNA expression of tight-junction proteins. Gut microbiota profile was determined by 16S rDNA pyrosequencing. Tumor necrosis factor (TNF)-α and interleukin (IL)-6 mRNA levels were measured in proximal colon, adipose tissue and liver using RT-qPCR. Adipose macrophage infiltration (F4/80+) was assessed using immunohistochemical staining. HFD mice had a higher insulin/glucose ratio (P = 0.020) and serum levels of serum amyloid A3 (131%; P = 0.008) but reduced circulating adiponectin (64%; P = 0.011). In proximal colon of HFD mice compared to mice fed the control diet, transepithelial resistance and mRNA expression of zona occludens 1 were reduced by 38% (P<0.001) and 40% (P = 0.025) respectively and TNF-α mRNA level was 6.6-fold higher (P = 0.037). HFD reduced Lactobacillus (75%; P<0.001) but increased Oscillibacter (279%; P = 0.004) in fecal microbiota. Correlations were found between abundances of Lactobacillus (r = 0.52; P = 0.013) and Oscillibacter (r = −0.55; P = 0.007) with transepithelial resistance of the proximal colon. HFD increased macrophage infiltration (58%; P = 0.020), TNF-α (2.5-fold, P<0.001) and IL-6 mRNA levels (2.5-fold; P = 0.008) in mesenteric fat. Increased macrophage infiltration in epididymal fat was also observed with HFD feeding (71%; P = 0.006) but neither TNF-α nor IL-6 was altered. Perirenal and subcutaneous adipose tissue showed no signs of inflammation in HFD mice. The current results implicate gut dysfunction, and attendant inflammation of contiguous adipose, as salient features of the metabolic dysregulation of diet-induced obesity.
Collapse
Affiliation(s)
- Yan Y Lam
- Boden Institute of Obesity, Nutrition, Exercise and Eating Disorders, University of Sydney, Sydney, Australia.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
434
|
A protective strategy against hyperinflammatory responses requiring the nontranscriptional actions of GPS2. Mol Cell 2012; 46:91-104. [PMID: 22424771 DOI: 10.1016/j.molcel.2012.01.025] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/12/2011] [Revised: 09/07/2011] [Accepted: 01/24/2012] [Indexed: 02/08/2023]
Abstract
The association between hyperinflammatory states and numerous diseases is widely recognized, but our understanding of the molecular strategies that have evolved to prevent uncontrolled activation of inflammatory responses remains incomplete. Here, we report a critical, nontranscriptional role of GPS2 as a guardian against hyperstimulation of the TNF-α-induced gene program. GPS2 cytoplasmic actions are required to specifically modulate RIP1 ubiquitylation and JNK activation by inhibiting TRAF2/Ubc13 enzymatic activity. In vivo relevance of GPS2 anti-inflammatory role is confirmed by inhibition of TNF-α target genes in macrophages and by improved insulin signaling in the adipose tissue of aP2-GPS2 transgenic mice. As the nontranscriptional role is complemented by GPS2 functioning as positive and negative cofactor for nuclear receptors, in vivo overexpression also results in elevated circulating level of Resistin and development of hepatic steatosis. Together, these studies define GPS2 as a molecular guardian required for precise control of inflammatory responses involved in immunity and homeostasis.
Collapse
|
435
|
Polvani S, Tarocchi M, Galli A. PPARγ and Oxidative Stress: Con(β) Catenating NRF2 and FOXO. PPAR Res 2012; 2012:641087. [PMID: 22481913 PMCID: PMC3317010 DOI: 10.1155/2012/641087] [Citation(s) in RCA: 173] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2011] [Revised: 11/05/2011] [Accepted: 11/17/2011] [Indexed: 12/22/2022] Open
Abstract
Peroxisome-proliferator activator receptor γ (PPARγ) is a nuclear receptor of central importance in energy homeostasis and inflammation. Recent experimental pieces of evidence demonstrate that PPARγ is implicated in the oxidative stress response, an imbalance between antithetic prooxidation and antioxidation forces that may lead the cell to apoptotic or necrotic death. In this delicate and intricate game of equilibrium, PPARγ stands out as a central player devoted to the quenching and containment of the damage and to foster cell survival. However, PPARγ does not act alone: indeed the nuclear receptor is at the point of interconnection of various pathways, such as the nuclear factor erythroid 2-related factor 2 (NRF2), Wnt/β-catenin, and forkhead box proteins O (FOXO) pathways. Here we reviewed the role of PPARγ in response to oxidative stress and its interaction with other signaling pathways implicated in this process, an interaction that emerged as a potential new therapeutic target for several oxidative-related diseases.
Collapse
Affiliation(s)
- Simone Polvani
- Gastroenterology Unit, Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy
| | - Mirko Tarocchi
- Gastroenterology Unit, Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy
| | - Andrea Galli
- Gastroenterology Unit, Department of Clinical Pathophysiology, University of Florence, Viale Pieraccini 6, 50139 Firenze, Italy
| |
Collapse
|
436
|
Olson NC, Callas PW, Hanley AJG, Festa A, Haffner SM, Wagenknecht LE, Tracy RP. Circulating levels of TNF-α are associated with impaired glucose tolerance, increased insulin resistance, and ethnicity: the Insulin Resistance Atherosclerosis Study. J Clin Endocrinol Metab 2012; 97:1032-40. [PMID: 22238388 PMCID: PMC3319215 DOI: 10.1210/jc.2011-2155] [Citation(s) in RCA: 68] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
OBJECTIVE Although several epidemiological studies have investigated associations between TNF-α and insulin resistance, results have been inconsistent. We studied the relationship between TNF-α and glucose tolerance status as part of the Insulin Resistance Atherosclerosis Study. RESEARCH DESIGN AND METHODS Serum concentrations of TNF-α were measured in 1558 individuals in a triethnic population across a spectrum of glucose tolerance. Insulin sensitivity and insulin secretion were assessed by a frequently sampled iv glucose tolerance test (FSIGT). RESULTS Compared with those with normal glucose tolerance, circulating levels of TNF-α were elevated in individuals with impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2D) after adjusting for age, gender, ethnicity, clinic site, and body mass index (3.3, 3.5, and 3.7 pg/ml in subjects with normal glucose tolerance, IGT, and T2D, respectively; P<0.05). Age-, sex-, and body mass index-adjusted levels of TNF-α differed by ethnicity, with Hispanics having the highest levels and African-Americans having the lowest (4.1, 3.6, and 3.0 pg/ml in Hispanics, non-Hispanic whites, and African-Americans, respectively; P<0.05). TNF-α was correlated with waist circumference, high-density lipoprotein, triglycerides, plasminogen activator inhibitor-1 and insulin sensitivity index (SI) (r=0.22, -0.30, 0.35, 0.31, and -0.25; P<0.0001); however, correlations varied by ethnicity. After adjusting for demographics and adiposity, individuals characterized by increased insulin resistance (lower SI), had higher levels of TNF-α than subjects characterized by high insulin sensitivity (3.8 and 3.3 pg/ml in subjects with an SI below/above the median at baseline; P<0.0001). No differences were found for acute insulin response. CONCLUSIONS We confirm that TNF-α is associated with IGT and T2D in a large, multiethnic population, independent of measures of adiposity. Adjusted values of TNF-α, as well as relationships between TNF-α and variables related to T2D, varied by ethnicity. Increased TNF-α levels were predominantly associated with insulin resistance but not with primary defects in β-cell function.
Collapse
Affiliation(s)
- Nels C Olson
- Department of PathologyUniversity of Vermont College of Medicine, Burlington, VT 05405, USA
| | | | | | | | | | | | | |
Collapse
|
437
|
Schoenberg KM, Perfield KL, Farney JK, Bradford BJ, Boisclair YR, Overton TR. Effects of prepartum 2,4-thiazolidinedione on insulin sensitivity, plasma concentrations of tumor necrosis factor-α and leptin, and adipose tissue gene expression. J Dairy Sci 2012; 94:5523-32. [PMID: 22032375 DOI: 10.3168/jds.2011-4501] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/30/2011] [Accepted: 07/15/2011] [Indexed: 11/19/2022]
Abstract
Administration of peroxisome proliferator-activated receptor gamma (PPARγ) ligands, thiazolidinediones (TZD), to prepartum dairy cattle has been shown to improve dry matter intake and decrease circulating nonesterified fatty acids (NEFA) around the time of calving. The objective of this work was to elucidate mechanisms of TZD action in transition dairy cattle by investigating changes in plasma leptin, tumor necrosis factor-α (TNFα), the revised quantitative insulin sensitivity check index (RQUICKI), and adipose tissue gene expression of leptin, PPARγ, lipoprotein lipase (LPL), and fatty acid synthase (FAS). Multiparous Holstein cows (n=40) were administered 0, 2.0, or 4.0 mg of TZD/kg of body weight (BW) by intrajugular infusion once daily from 21 d before expected parturition until parturition. Plasma samples collected daily from 22 d before expected parturition through 21 d postpartum were analyzed for glucose, NEFA, and insulin. Plasma samples collected on d -14, -3, -1, 1, 3, 7, 14, and 49 relative to parturition were also analyzed for leptin and TNFα. Adipose tissue was collected on d 7 before expected parturition from a subset of cows, and gene expression was examined via quantitative real-time PCR. A tendency for a treatment by time effect on plasma leptin prepartum was observed such that values were similar on d -14 but cows receiving 2.0 mg/kg of BW of TZD tended to have lower circulating leptin as calving approached. Postpartum leptin tended to be increased linearly (2.3, 2.4, and 2.5±0.1 ng/mL for 0, 2.0, and 4.0 mg/kg treatments, respectively) in cows that received TZD prepartum. Plasma TNFα increased linearly (2.6, 3.7, and 4.0±0.1 pg/mL) in response to TZD treatment and decreased through the first week postpartum. Calculation of RQUICKI 1/[log(glucose)+log(insulin)+log(NEFA)] suggested altered insulin sensitivity in cows administered TZD that may depend on day relative to calving. Administration of TZD increased adipose tissue expression of PPARγ mRNA (11.0, 13.3, and 12.8±1.9). Administration of TZD had a quadratic effect on gene expression of leptin (16.2, 10.7, and 17.4±1.6) and no effect on LPL expression, and expression of FAS was lower for TZD-treated cows than for controls (8.2, 4.2, and 6.1±1.8, respectively). Results imply altered expression and plasma concentrations of leptin, increased plasma TNFα concentrations, and increased expression of PPARγ in adipose tissue as potential mechanisms for the effects of TZD administration on transition dairy cattle.
Collapse
Affiliation(s)
- K M Schoenberg
- Department of Animal Science, Cornell University, Ithaca, NY 14853, USA
| | | | | | | | | | | |
Collapse
|
438
|
Matsunaga T, Shoji A, Gu N, Joo E, Li S, Adachi T, Yamazaki H, Yasuda K, Kondoh T, Tsuda K. γ-Tocotrienol attenuates TNF-α-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes. Mol Med Rep 2012; 5:905-9. [PMID: 22293775 PMCID: PMC3493080 DOI: 10.3892/mmr.2012.770] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2011] [Accepted: 12/22/2011] [Indexed: 01/22/2023] Open
Abstract
Tocotrienols, members of the vitamin E family, have been shown to possess anti-inflammatory properties and display activity against a variety of chronic diseases, such as cancer, cardiovascular and neurological diseases. However, whether tocotrienols contribute to the prevention of inflammatory responses in adipose tissue remains to be elucidated. In this study, we examined the effects of γ-tocotrienol, the most common tocotrienol isomer, on tumor necrosis factor-α (TNF-α)-induced inflammatory responses by measuring the expression of the adipokines, monocyte chemoattractant protein-1 (MCP-1), interleukin-6 (IL-6) and adiponectin in 3T3-L1 adipocytes. Exposure to TNF-α (10 ng/ml) for 24 h increased MCP-1 and IL-6 secretion, and decreased adiponectin secretion and peroxisome proliferator-activated receptor-γ (PPARγ) mRNA expression. γ-tocotrienol effectively improved the TNF-α-induced adverse changes in MCP-1, IL-6 and adiponectin secretion, and in MCP-1, IL-6, adiponectin and PPARγ mRNA expression. Furthermore, TNF-α-mediated IκB-α phosphorylation and nuclear factor-κB (NF-κB) activation were significantly suppressed by the γ-tocotrienol treatment. Our results suggest that γ-tocotrienol may improve obesity-related functional abnormalities in adipocytes by attenuating NF-κB activation and the expression of inflammatory adipokines.
Collapse
Affiliation(s)
- Tetsuro Matsunaga
- Ajinomoto Integrative Research for Advanced Dieting, Graduate School of Agriculture, Kyoto University, Kyoto, Japan
| | | | | | | | | | | | | | | | | | | |
Collapse
|
439
|
Mencarelli A, Francisci D, Renga B, D'Amore C, Cipriani S, Basile F, Schiaroli E, Baldelli F, Fiorucci S. Ritonavir-induced lipoatrophy and dyslipidaemia is reversed by the anti-inflammatory drug leflunomide in a PPAR-γ-dependent manner. Antivir Ther 2012; 17:669-78. [PMID: 22297608 DOI: 10.3851/imp2039] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/29/2011] [Indexed: 10/14/2022]
Abstract
BACKGROUND The complex interplay between viral infection and virus-activated inflammatory pathways with protease inhibitors (PIs) contributes to the increased risk of developing atherosclerosis and coronary artery disease in HIV-infected patients. Leflunomide is an antirheumatic drug whose administration to HIV-1-infected persons effectively decreases T-cell turnover and activation. In this study we have investigated the effects of leflunomide on dyslipidaemia and lipodistrophy induced by ritonavir in rodents. METHODS Mice were administered ritonavir (5 mg/kg/day) alone or in combination with leflunomide (40 mg/kg/day) for 12 days. Expression of nuclear receptor and lipidogenetic genes was measured in liver and adipose tissues. RESULTS Administration of the HIV PI ritonavir to mice increased plasma triacylglycerols, free fatty acids and cholesterol levels, and this effect was reverted by cotreatment with leflunomide. Ritonavir administration was associated with reduced epididymal fat/body weight ratio and increased liver content of triacylglycerols content. These effects were reverted by leuflunomide. Histopathology analysis shows that exposure to ritonavir causes inflammation of epididymal fat as demonstrated by dense leukocytes infiltration as well as by increased levels of proinflammatory mediators and reduced expression and activity of peroxisome proliferator-activated receptor-γ (PPAR-γ). Leflunomide reduced epididymal fat inflammatory-metabolic alteration induced by ritonavir and restored PPAR-γ expression in the epididymal fat. CONCLUSIONS We have shown that the anti-inflammatory drug leflunomide protects against ritonavir-induced inflammation and dysmetabolism in adipose tissue and might be a promising strategy in the setting of HIV-infected patients at risk for HIV-induced dyslipidaemia.
Collapse
Affiliation(s)
- Andrea Mencarelli
- Dipartimento di Medicina Clinica e Sperimentale, Facoltà di Medicina e Chirurgia, University of Perugia, S. Andrea delle Fratte, Perugia, Italy.
| | | | | | | | | | | | | | | | | |
Collapse
|
440
|
Inflammation and type 2 diabetes. DIABETES & METABOLISM 2012; 38:183-91. [PMID: 22252015 DOI: 10.1016/j.diabet.2011.11.006] [Citation(s) in RCA: 319] [Impact Index Per Article: 26.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/19/2011] [Revised: 11/29/2011] [Accepted: 11/30/2011] [Indexed: 02/07/2023]
Abstract
Low-grade inflammation is a common feature in subjects with type 2 diabetes (T2D). Heart disease, the metabolic syndrome and T2D all have in common the increased concentration of circulatory cytokines as a result of inflammation. Inflammatory cytokines are produced by different cell types and secreted into the circulation, where they regulate different tissues through their local, central and peripheral actions. This review focuses on C-reactive protein (CRP), a well-established marker of the development of inflammation, on tumour necrosis factor (TNF)-α, an inflammatory marker strongly associated with diabetes, and on adiponectin, a cytokine produced by adipose tissue and associated with insulin sensitivity. While it is clear from the literature that these cytokines play a major role in the development of T2D or, in the case of adiponectin, its prevention, the best strategy for favourably altering the inflammatory response is still a matter of debate.
Collapse
|
441
|
Daniele A, De Rosa A, De Cristofaro M, Monaco ML, Masullo M, Porcile C, Capasso M, Tedeschi G, Oriani G, Di Costanzo A. Decreased concentration of adiponectin together with a selective reduction of its high molecular weight oligomers is involved in metabolic complications of myotonic dystrophy type 1. Eur J Endocrinol 2011; 165:969-75. [PMID: 21964963 DOI: 10.1530/eje-11-0537] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
OBJECTIVE The hormone adiponectin exerts beneficial pleiotropic effects on biological and metabolic processes. Although a well-recognized insulin sensitizer, its characteristic has yet to be clearly defined. Myotonic dystrophy type 1 (DM1) is a rare genetic disorder that features muscle wasting and metabolic comorbidity, and patients have an increased risk of developing type 2 diabetes. We analyzed circulating levels of adiponectin and its oligomers to determine whether their expression correlates with metabolic alterations in DM1 patients. DESIGN AND METHODS We measured the anthropometric and biochemical features and three insulin resistance (IR) indices (homeostasis model assessment, quantitative insulin sensitivity check index, and McAuley) of 21 DM1 patients and of 82 age-, sex-, and weight-matched controls. In the blood samples of patients and controls, adiponectin levels were measured by ELISA, and its oligomers were characterized by using western blotting and gel filtration. The adiponectin gene was molecularly analyzed in patients. RESULTS DM1 patients had significantly higher body mass index, waist circumference, triglycerides (TGs), glucose, tumor necrosis factor α, and IR; conversely, they had significantly lower concentrations of total serum adiponectin with a selective, pronounced decrease of its high molecular weight (HMW) oligomers. There was a strong negative correlation between adiponectin and TGs in DM1 patients. CONCLUSIONS Our results endorse the hypothesis that decreased expression of adiponectin together with a selective reduction of its HMW oligomers contributes to the worsening of IR and its metabolic complications in DM1 patients. These findings suggest that adiponectin and HMW oligomers may serve as biomarkers and are promising therapeutic agents for IR and its consequences in DM1.
Collapse
Affiliation(s)
- Aurora Daniele
- CEINGE Biotecnologie Avanzate Scarl, Via Gaetano Salvatore 486, Naples, Italy.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
442
|
Schulze PC, Biolo A, Gopal D, Shahzad K, Balog J, Fish M, Siwik D, Colucci WS. Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure. J Card Fail 2011; 17:1004-11. [PMID: 22123363 PMCID: PMC3226951 DOI: 10.1016/j.cardfail.2011.08.010] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2011] [Revised: 08/17/2011] [Accepted: 08/18/2011] [Indexed: 01/09/2023]
Abstract
BACKGROUND Patients with heart failure (HF) develop metabolic derangements including increased adipokine levels, insulin resistance, inflammation and progressive catabolism. It is not known whether metabolic dysfunction and adipocyte activation worsen in the setting of acute clinical decompensation, or conversely, improve with clinical recovery. METHODS AND RESULTS We assessed insulin resistance using homeostasis model assessment of insulin resistance (HOMA-IR), and measured plasma levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP), adiponectin, visfatin, resistin, leptin, and tumor necrosis factor (TNF) α in 44 patients with acute decompensated HF (ADHF) due to left ventricular (LV) systolic dysfunction and again early (<1 wk) and late (> 6 mo) after clinical recovery, in 26 patients with chronic stable HF, and in 21 patients without HF. NT-proBNP was not increased in control subjects, mildly elevated in patients with stable HF, markedly elevated in patients with ADHF, and decreased progressively early and late after treatment. Compared to control subjects, plasma adiponectin, visfatin, leptin, resistin, and TNF-α were elevated in patients with chronic stable HF and increased further in patients with ADHF. Likewise, HOMA-IR was increased in chronic stable HF and increased further during ADHF. Adiponectin, visfatin, and HOMA-IR remained elevated at the time of discharge from the hospital, but returned to chronic stable HF levels. Adipokine levels were not related to body mass index in HF patients. HOMA-IR correlated positively with adipokines and TNF-α in HF patients. CONCLUSIONS ADHF is associated with worsening of insulin resistance and elevations of adipokines and TNF-α, indicative of adipocyte activation. These metabolic abnormalities are reversible, but they temporally lag behind the clinical resolution of decompensated HF.
Collapse
Affiliation(s)
- P Christian Schulze
- Division of Cardiology, New York-Presbyterian Hospital/Columbia University Medical Center, New York, New York 10032, USA.
| | | | | | | | | | | | | | | |
Collapse
|
443
|
Hanses F, Kopp A, Bala M, Buechler C, Falk W, Salzberger B, Schäffler A. Intracellular survival of Staphylococcus aureus in adipocyte-like differentiated 3T3-L1 cells is glucose dependent and alters cytokine, chemokine, and adipokine secretion. Endocrinology 2011; 152:4148-57. [PMID: 21914779 DOI: 10.1210/en.2011-0103] [Citation(s) in RCA: 25] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Although obesity and type 2 diabetes mellitus are associated with Gram-positive infections and a worse clinical outcome, it is unknown whether adipocytes can be infected by Gram-positive bacteria. Adipocyte-like differentiated 3T3-L1 cells and Staphylococcus aureus were used for infection experiments under normoglycemic (100 mg/dl) and hyperglycemic (450 mg/dl) conditions in the presence/absence of insulin (1 μm). Intracellular presence and survival of S. aureus was investigated quantitatively. Supernatant cytokines, chemokines, and adipokines were measured by ELISA. Lipid metabolism and cellular morphology of infected adipocytes were investigated by different techniques. The present study provides the proof of principle that adipocyte-like cells can be infected by S. aureus dose dependently for up to 5 d. Importantly, low bacterial inocula did not affect cell viability. Intracellular survival of S. aureus was glucose dependent but not insulin dependent, and insulin receptor expression and insulin receptor signaling were not altered. Infection increased macrophage chemoattractant protein-1, visfatin, and IL-6 secretion, whereas resistin and adiponectin were decreased. Infected adipocytes had higher intracellular triacylglycerol concentrations and larger lipid droplets because of a decreased lipolysis. Taken together, infection of adipocytes by S. aureus is glucose dependent, inhibits cellular lipolysis, and affects the secretion of immunomodulating adipokines differentially. Because cell viability is not affected during infection, adipose tissue might function as a host for chronic infection by bacteria-causing metabolic, proinflammatory, and prodiabetic disturbances.
Collapse
Affiliation(s)
- Frank Hanses
- Department of Internal Medicine I, University Hospital Regensburg, Franz-Josef-Strauss Allee 11, 93042 Regensburg, Germany.
| | | | | | | | | | | | | |
Collapse
|
444
|
García-García FJ, Larrión Zugasti JL, Rodríguez Mañas L. [Frailty: a phenotype under review]. GACETA SANITARIA 2011; 25 Suppl 2:51-8. [PMID: 22033007 DOI: 10.1016/j.gaceta.2011.08.001] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/24/2011] [Revised: 07/25/2011] [Accepted: 08/11/2011] [Indexed: 01/04/2023]
Abstract
A person's biological condition in old age partly depends on previous lifestyles. Consequently, the relationship between physical activity and obesity is emerging as an important risk factor for frailty, especially due to the resulting chronic inflammatory state. This inflammation not only leads to sarcopenia, which is basic to the development of frailty, but also affects the vascular and central nervous systems. Therefore, we believe that these two systems should be included in the frailty phenotype. Under these premises, and using the data from the Toledo Study for Healthy Aging, we propose that the frailty phenotype be extended and recommend the use of a scale to evaluate the frailty trait.
Collapse
|
445
|
Eisinger K, Bauer S, Schäffler A, Walter R, Neumann E, Buechler C, Müller-Ladner U, Frommer KW. Chemerin induces CCL2 and TLR4 in synovial fibroblasts of patients with rheumatoid arthritis and osteoarthritis. Exp Mol Pathol 2011; 92:90-6. [PMID: 22037282 DOI: 10.1016/j.yexmp.2011.10.006] [Citation(s) in RCA: 58] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2011] [Accepted: 10/11/2011] [Indexed: 01/15/2023]
Abstract
INTRODUCTION Chemerin stimulates migration of leukocytes to sites of inflammation and also increases inflammatory signaling in chondrocytes suggesting a function of chemerin in joint inflammation. Synovial fibroblasts (SF) are critically involved in synovitis and subsequent cartilage destruction. Here, we analyzed whether synovial fibroblasts express chemerin and its receptor CMKLR1. Further, the role of chemerin in synovial fibroblast chemotaxis, proliferation, insulin response and release of inflammatory proteins was studied. METHODS Synovial tissue sections were labeled with chemerin antibody and chemerin was measured in synovial fluid by ELISA. Chemerin mRNA and protein as well as CMKLR1 expression were determined in SFs from patients with osteoarthritis (OA) and rheumatoid arthritis (RA). Effects of chemerin on cytokines, chemokines and matrix metalloproteinases (MMP), and on proliferation, migration and insulin signaling were analyzed appropriately. RESULTS SFs expressed CMKLR1 and chemerin mRNA, and chemerin protein was found in cell supernatants of synovial fibroblasts. Immunohistochemistry detected chemerin in synovial tissue predominantly localized within the lining layer. Chemerin was present in synovial fluids of RA, OA and psoriatic arthritis patients in similar concentrations. Chemerin neither increased IL-6 levels nor MMP-2 or -9 activity in SFs. Also, it did not act as a chemoattractant for these cells. With respect to intracellular signaling, neither basal nor insulin-mediated phosphorylation of Akt was affected. However, chemerin significantly increased TLR4 mRNA and synthesis of CCL2 in SFs while CCL4 and -5 were not altered. Cell proliferation of SFs, however, was modestly reduced by chemerin. CONCLUSIONS These data show that human SFs express both chemerin and its receptor. As chemerin enhanced expression of TLR4 and induced release of CCL2 in SFs, a role of this protein in innate immune system-associated joint inflammation is proposed.
Collapse
Affiliation(s)
- Kristina Eisinger
- Department of Internal Medicine I, Regensburg University Hospital, D-93042 Regensburg, Germany
| | | | | | | | | | | | | | | |
Collapse
|
446
|
Yang X, Zhang X, Heckmann BL, Lu X, Liu J. Relative contribution of adipose triglyceride lipase and hormone-sensitive lipase to tumor necrosis factor-α (TNF-α)-induced lipolysis in adipocytes. J Biol Chem 2011; 286:40477-85. [PMID: 21969372 DOI: 10.1074/jbc.m111.257923] [Citation(s) in RCA: 83] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/24/2023] Open
Abstract
TNF-α potently stimulates basal lipolysis in adipocytes, which may contribute to hyperlipidemia and peripheral insulin resistance in obesity. Recent studies show that adipose triglyceride lipase (ATGL) and hormone-sensitive lipase (HSL) act sequentially in catalyzing the first two steps of adipose lipolysis in response to β-adrenergic stimulation. Here, we sought to determine their functional roles in TNF-α-induced lipolysis. Silencing of ATGL expression in adipocytes almost completely abolished basal and TNF-α-induced glycerol release. In comparison, the glycerol release under the same conditions was only partially decreased upon reduction in expression of either HSL or the ATGL coactivator CGI-58. Interestingly, overexpression of ATGL restored the lipolytic rates in cells with silenced HSL or CGI-58, indicating a predominant role for ATGL. While expression of ATGL, HSL and CGI-58 remains mostly unaffected, TNF-α treatment caused a rapid abrogation of the ATGL inhibitory protein G0S2. TNF-α drastically decreased the level of G0S2 mRNA, and the level of G0S2 protein could be maintained by inhibiting proteasomal protein degradation using MG-132. Furthermore, coexpression of G0S2 was able to significantly decrease TNF-α-stimulated lipolysis mediated by overexpressed ATGL or CGI-58. We propose that the early reduction in G0S2 content is permissive for TNF-α-induced lipolysis.
Collapse
Affiliation(s)
- Xingyuan Yang
- Department of Biochemistry and Molecular Biology, Mayo Clinic, Scottsdale, Arizona 85259, USA
| | | | | | | | | |
Collapse
|
447
|
Liu S, Yang Y, Wu J. TNFα-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. Biochem Biophys Res Commun 2011; 414:618-24. [PMID: 21986534 DOI: 10.1016/j.bbrc.2011.09.131] [Citation(s) in RCA: 97] [Impact Index Per Article: 7.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2011] [Accepted: 09/27/2011] [Indexed: 01/14/2023]
Abstract
Tumor necrosis factor α (TNFα) is known to inhibit adipogenesis, but the molecular mechanism of this inhibition remains elusive. In the present study, we found that TNFα-induced inhibition of adipogenesis mainly occurs when 3T3-L1 preadipocytes are treated with TNFα within 2h induction of adipogenesis. We revealed that TNFα treatment results in the up-regulation of miR-155 through the NFκB pathway in 3T3-L1 cells. This overexpression of miR-155 may suppress the expression of C/EBPβ and CREB by directly targeting their 3' untranslated regions (3' UTRs). Importantly, anti-miR-155 reduces the TNFα-induced inhibition of adipogenesis, whereas exogenous expression of mir-155 inhibits adipogenesis. Taken together, these findings reveal a novel role for TNFα in the regulation of anti-adipogenic miRNAs.
Collapse
Affiliation(s)
- Sanhong Liu
- Key Laboratory of Systems Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200031, China
| | | | | |
Collapse
|
448
|
Kruger I, Huisman H, Schutte A. The relationship between adiponectin, ageing and renal function in a bi-ethnic sample. ACTA ACUST UNITED AC 2011; 169:58-63. [DOI: 10.1016/j.regpep.2011.04.003] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2010] [Revised: 03/09/2011] [Accepted: 04/16/2011] [Indexed: 12/20/2022]
|
449
|
Lewis JP, Shuldiner AR. Genetics of the metabolic complications of obesity. PROGRESS IN MOLECULAR BIOLOGY AND TRANSLATIONAL SCIENCE 2011; 94:349-72. [PMID: 21036331 DOI: 10.1016/b978-0-12-375003-7.00012-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Joshua P Lewis
- University of Maryland School of Medicine, Baltimore, Maryland, USA
| | | |
Collapse
|
450
|
Abstract
Tumor necrosis factor-alpha (TNF-α) is recognized as a cytokine because of its involvement in inflammation-mediated biological defense functions. Although TNF-α is primarily produced by macrophages, it is also produced by other cells, including lymphocytes, Kupffer cells, natural killer cells and adipocytes. While TNF-α has diverse immune system functions, including antitumor activity, antimicrobial activity and mediation of inflammation, it also regulates a number of physiological functions, including appetite, fever, energy metabolism and endocrine activity. Factors such as viruses, parasites, other cytokines, and endotoxins induce TNF-α production. In combination with other cytokines, TNF-α plays a clinically important role in cattle by mediating immune inflammatory responses such as mastitis and endotoxic shock. It has been reported that cytokines such as TNF-α are involved in metabolic disease such as acidosis. On the other hand, several data suggest that lactoferrin (LF) acts to prevent the release of a number of inflammatory mediators from various activated cells, and further suggest that the prophylactic effect of LF involves inhibition of cytokine production, including TNF-α, that are principal mediators of the inflammatory response leading to death from toxic shock. This review discusses the role of TNF-α in pathological conditions in cattle, including infections and metabolic diseases caused by perturbation of metabolism and endocrine functions.
Collapse
Affiliation(s)
- Shiro Kushibiki
- National Institute of Livestock and Grassland Science, Tsukuba, Japan.
| |
Collapse
|